Clinical Trial Update: A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis [NA]

View source ↗

Summary

This completed randomized, open-label, two-way crossover study compared the pharmacokinetics of metoclopramide when administered as an orally disintegrating tab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Gastroparesis

Drugs mentioned

• Metoclopramide (metoclopramide)
• Reglan (metoclopramide)

Snippet

Sponsor: UCB Pharma | Conditions: Diabetic Gastroparesis | NA | Status: COMPLETED